hnulp1, a basic helix-loop-helix protein with a novel transcriptional repressive domain, inhibits transcriptional activity of serum response factor

2006 ◽  
Vol 343 (3) ◽  
pp. 973-981 ◽  
Author(s):  
Zhenyu Cai ◽  
Yuequn Wang ◽  
Weishi Yu ◽  
Jing Xiao ◽  
Yongqing Li ◽  
...  
1996 ◽  
Vol 271 (9) ◽  
pp. 5258-5264 ◽  
Author(s):  
Regina Groisman ◽  
Hiroshi Masutani ◽  
Marie-Pierre Leibovitch ◽  
Philippe Robin ◽  
Isabelle Soudant ◽  
...  

2000 ◽  
Vol 275 (17) ◽  
pp. 12941-12947 ◽  
Author(s):  
Corine Bertolotto ◽  
Jean-Ehrland Ricci ◽  
Frédéric Luciano ◽  
Bernard Mari ◽  
Jean-Claude Chambard ◽  
...  

2005 ◽  
Vol 25 (18) ◽  
pp. 8009-8023 ◽  
Author(s):  
Keiko Kawai-Kowase ◽  
Meena S. Kumar ◽  
Mark H. Hoofnagle ◽  
Tadashi Yoshida ◽  
Gary K. Owens

ABSTRACT Although a critical component of vascular disease is modulation of the differentiated state of vascular smooth muscle cells (SMC), the mechanisms governing SMC differentiation are relatively poorly understood. We have previously shown that E-boxes and the ubiquitously expressed class I basic helix-loop-helix (bHLH) proteins, including E2-2 and E12, are important in regulation of the SMC differentiation marker gene, the SM α-actin gene. The aim of the present study was to identify proteins that bind to class I bHLH proteins in SMC and modulate transcriptional regulation of SMC differentiation marker genes. Herein we report that members of the protein inhibitor of activated STAT (PIAS) family interact with class I bHLH factors as well as serum response factor (SRF). PIAS1 interacted with E2-2 and E12 based on yeast two-hybrid screens, mammalian two-hybrid assays, and/or coimmunoprecipitation assays. Overexpression of PIAS1 significantly activated the SM α-actin promoter and mRNA expression, as well as SM myosin heavy chain and SM22α, whereas a small interfering RNA for PIAS1 decreased activity of these promoters, as well as endogenous mRNA expression, and SRF binding to SM α-actin promoter within intact chromatin in cultured SMC. Of significance, PIAS1 bound to SRF and activated SM α-actin promoter expression in wild-type but not SRF−/− embryonic stem cells. These results provide novel evidence that PIAS1 modulates transcriptional activation of SMC marker genes through cooperative interactions with both SRF and class I bHLH proteins.


2021 ◽  
Vol 8 (5) ◽  
pp. 58
Author(s):  
Hazel Aberdeen ◽  
Kaela Battles ◽  
Ariana Taylor ◽  
Jeranae Garner-Donald ◽  
Ana Davis-Wilson ◽  
...  

The fastest growing demographic in the U.S. at the present time is those aged 65 years and older. Accompanying advancing age are a myriad of physiological changes in which reserve capacity is diminished and homeostatic control attenuates. One facet of homeostatic control lost with advancing age is glucose tolerance. Nowhere is this more accentuated than in the high proportion of older Americans who are diabetic. Coupled with advancing age, diabetes predisposes affected subjects to the onset and progression of cardiovascular disease (CVD). In the treatment of type 2 diabetes, hypoglycemic episodes are a frequent clinical manifestation, which often result in more severe pathological outcomes compared to those observed in cases of insulin resistance, including premature appearance of biomarkers of senescence. Unfortunately, molecular mechanisms of hypoglycemia remain unclear and the subject of much debate. In this review, the molecular basis of the aging vasculature (endothelium) and how glycemic flux drives the appearance of cardiovascular lesions and injury are discussed. Further, we review the potential role of the serum response factor (SRF) in driving glycemic flux-related cellular signaling through its association with various proteins.


Sign in / Sign up

Export Citation Format

Share Document